the role and targeting of immune dysregulation in mds
Published 1 year ago • 86 plays • Length 1:38Download video MP4
Download video MP3
Similar videos
-
1:37
the role of the innate immune system in mds & the value of targeting immune signaling pathways
-
2:49
the role of the immune system in the pathophysiology of mds
-
2:06
understanding the role of inflammation and the immunome in mds pathophysiology
-
1:48
immune therapy approaches in mds
-
4:27
the role of immune checkpoint inhibitors in mds
-
3:17
pre-mds states: novel therapeutic approaches, and determining appropriate trial endpoints
-
1:41
an overview of the mds diagnosis pathway
-
9:41
the i4mds consortium and immune monitoring in mds
-
4:32
recent advances in the treatment of lr-mds: commands and imerge trial data
-
6:15
targeting ror-1 with zilovertamab in mcl and cll
-
50:56
chip and ccus, precursors to mds
-
1:34
sequencing of agents in lr-mds
-
2:10
using the innate immune system to treat mds & the value of novel immunotherapies
-
3:11
clinical characteristics of h-mds
-
3:10
the role of ngs in mds diagnosis
-
1:33
the current guidelines and therapies for tp53-mutated mds and aml
-
5:33
clinical utility of the homologous recombination deficiency score in aml & mds
-
4:44
immunotherapy in mds
-
1:36
integrated sequencing utilized in a timely and impactful manner in aml/mds
-
2:07
emerging targeted treatments for mds
-
1:30
the prognostic value of patient-reported outcomes in mds